Viva Biotech Holdings (FRA:VB0)

Viva Biotech Holdings Statistics

Total Valuation

FRA:VB0 has a market cap or net worth of EUR 520.27 million. The enterprise value is 551.98 million.

Market Cap	520.27M
Enterprise Value	551.98M

Important Dates

The next estimated earnings date is Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	2.11B
Shares Outstanding	n/a
Shares Change (YoY)	+48.61%
Shares Change (QoQ)	-30.21%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.02B

Valuation Ratios

The trailing PE ratio is 25.41 and the forward PE ratio is 8.03.

PE Ratio	25.41
Forward PE	8.03
PS Ratio	2.38
PB Ratio	1.12
P/TBV Ratio	3.13
P/FCF Ratio	20.42
P/OCF Ratio	12.45
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.41, with an EV/FCF ratio of 21.67.

EV / Earnings	26.95
EV / Sales	2.53
EV / EBITDA	10.41
EV / EBIT	20.33
EV / FCF	21.67

Financial Position

The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.30.

Current Ratio	1.76
Quick Ratio	1.22
Debt / Equity	0.30
Debt / EBITDA	2.59
Debt / FCF	5.39
Interest Coverage	5.57

Financial Efficiency

Return on equity (ROE) is 5.87% and return on invested capital (ROIC) is 4.41%.

Return on Equity (ROE)	5.87%
Return on Assets (ROA)	2.03%
Return on Invested Capital (ROIC)	4.41%
Return on Capital Employed (ROCE)	3.88%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	104,706
Profits Per Employee	9,822
Employee Count	2,085
Asset Turnover	0.26
Inventory Turnover	4.24

Taxes

In the past 12 months, FRA:VB0 has paid 6.60 million in taxes.

Income Tax	6.60M
Effective Tax Rate	19.69%

Stock Price Statistics

The stock price has increased by +41.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+41.86%
50-Day Moving Average	0.23
200-Day Moving Average	0.23
Relative Strength Index (RSI)	51.94
Average Volume (20 Days)	702

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:VB0 had revenue of EUR 218.31 million and earned 20.48 million in profits. Earnings per share was 0.01.

Revenue	218.31M
Gross Profit	81.74M
Operating Income	27.17M
Pretax Income	33.51M
Net Income	20.48M
EBITDA	51.34M
EBIT	27.17M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 107.50 million in cash and 137.43 million in debt, with a net cash position of -29.93 million.

Cash & Cash Equivalents	107.50M
Total Debt	137.43M
Net Cash	-29.93M
Net Cash Per Share	n/a
Equity (Book Value)	464.45M
Book Value Per Share	0.22
Working Capital	89.67M

Cash Flow

In the last 12 months, operating cash flow was 41.78 million and capital expenditures -16.30 million, giving a free cash flow of 25.48 million.

Operating Cash Flow	41.78M
Capital Expenditures	-16.30M
Free Cash Flow	25.48M
FCF Per Share	n/a

Margins

Gross margin is 37.44%, with operating and profit margins of 12.45% and 9.38%.

Gross Margin	37.44%
Operating Margin	12.45%
Pretax Margin	15.35%
Profit Margin	9.38%
EBITDA Margin	23.52%
EBIT Margin	12.45%
FCF Margin	11.67%

Dividends & Yields

FRA:VB0 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.61%
Shareholder Yield	-48.61%
Earnings Yield	3.94%
FCF Yield	4.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:VB0 has an Altman Z-Score of 0.93 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.93
Piotroski F-Score	7